Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kevin B Kim

Showing results (131-140 of 134) with videos related to

Pageof 14
Sort By:
You have reached the last page of results.This site can display upto 134 results.
Nature|September 9, 2010
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaGideon Bollag, Peter Hirth, James Tsai, et al.
The Journal of Investigative Dermatology|August 23, 2014
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanomaAlan E Siroy, Genevieve M Boland, Denái R Milton, et al.
The British Journal of Dermatology|October 22, 2024
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanomaErin McGillivray, Karam Ashouri, Eftychia Chatziioannou, et al.
Cancers|January 10, 2026
Metastatic Uveal Melanoma Surveillance: A Delphi Panel ConsensusJuan Alban, R Christopher Bowen, David A Reichstein, et al.
Pageof 14

Showing results (131-140 of 134) with videos related to

Sort By:
Pageof 14
You have reached the last page of results.This site can display upto 134 results.
Nature|September 9, 2010
Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanomaGideon Bollag, Peter Hirth, James Tsai, et al.
The Journal of Investigative Dermatology|August 23, 2014
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanomaAlan E Siroy, Genevieve M Boland, Denái R Milton, et al.
The British Journal of Dermatology|October 22, 2024
Combined programmed cell death protein 1 and cytotoxic T-lymphocyte associated protein 4 blockade in an international cohort of patients with acral lentiginous melanomaErin McGillivray, Karam Ashouri, Eftychia Chatziioannou, et al.
Cancers|January 10, 2026
Metastatic Uveal Melanoma Surveillance: A Delphi Panel ConsensusJuan Alban, R Christopher Bowen, David A Reichstein, et al.
Pageof 14